trolamine salicylate has been researched along with Leukemia, Myelomonocytic, Acute in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexander, CB; DeAngelo, DJ; Helfgott, SM; Schwarzberg, AB | 1 |
Aroni, KG; Boki, KA; Kordossis, T; Stamoulis, K; Tzavara, V | 1 |
2 other study(ies) available for trolamine salicylate and Leukemia, Myelomonocytic, Acute
Article | Year |
---|---|
Clinical problem-solving. A joint venture.
Topics: Arthritis; Bone Marrow; Diagnosis, Differential; Dyspnea; Exanthema; Eye; Fatigue; Female; Humans; Joints; Leukemia, Myelomonocytic, Acute; Leukemic Infiltration; Leukocytes, Mononuclear; Middle Aged; Skin; Synovial Fluid; Urinary Bladder Neoplasms | 2008 |
Facial heliotrope rash as the initial manifestation of acute myelomonocytic leukemia.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arthritis; Bone Marrow; Cytarabine; Dermatitis; Face; Granulocyte Colony-Stimulating Factor; Humans; Keratosis; Leukemia, Myelomonocytic, Acute; Male; Mitoxantrone; Pancytopenia; Parotid Gland; Prednisolone | 1997 |